|
Canada-ON-CARNARVON Azienda Directories
|
Azienda News:
- Lucy Therapeutics
Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases
- Lucy Therapeutics Secures New Funding to Advance New . . . - Business Wire
Lucy Therapeutics is a private biotechnology company in Waltham, MA, founded by Amy Ripka, Ph D , in 2017, dedicated to unraveling the complex and interrelated biological processes driving
- Lucy Therapeutics Secures New Funding to Advance New . . . - BioSpace
Lucy Therapeutics, Inc today announced it has raised $12 5 million in additional funding led by existing investors Engine Ventures and Safar Partners with new participation from Bill Gates, Parkinson’s UK, and the Michael J Fox Foundation, which provided a $2 million non-dilutive grant
- Lucy Therapeutics Debuts Novel Therapeutic Agents for Parkinson’s . . .
Lucy Therapeutics’ proprietary compounds demonstrate promising preclinical efficacy, safety profiles via novel mechanism of action, validating new mitochondrial-based therapeutic approach for Parkinson’s Disease
- Lucy Therapeutics - Crunchbase Company Profile Funding
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria The company is offering a differentiated approach to drug discovery by drugging targets associated with early disease pathogenesis
- Lucy Therapeutics - The Engine
Breakthrough mitochondrial-based therapies for neurological diseases Imagine a world in which doctors can diagnose and treat patients before the tremors, the dementia, or the seizures from neurological diseases like Rett Syndrome, Alzheimer’s, and Parkinson’s take control This is a world that Lucy Therapeutics is working to realize
- Our Company - Lucy Therapeutics
Lucy Therapeutics is a private female-founded biotech company based in Waltham, MA, focused on developing proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers for the treatment of patients with complex diseases
- Lucy Therapeutics Parkinsons mitochondria research wins new funding
Lucy Therapeutics‘ (LucyTx) overall funding haul has grown to $36 million with the addition of $12 5 million more to support the company’s mitochondrial platform to develop new therapies for Parkinson’s disease
- Woman of the Week: Lucy Therapeutics’ Amy Ripka
After more than 20 years of working on drug discovery at Big Pharma, biotech and CRO companies, Amy Ripka, CEO and founder of Lucy Therapeutics, was motivated to find a new way to address unmet needs in CNS conditions like Parkinson’s and orphan diseases such as Rett syndrome
|
|